{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.2385G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "2385"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "795"
          },
          "Description in input context": "p.G2385R"
        },
        {
          "HGVS": "NM_001126112.3:c.1628C>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "C",
            "alt": "T",
            "position": "1628"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "P",
            "position": "543"
          },
          "Description in input context": "p.R1628P"
        },
        {
          "HGVS": "NM_001126112.3:c.1398C>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "C",
            "alt": "T",
            "position": "1398"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "H",
            "position": "466"
          },
          "Description in input context": "p.R1398H"
        },
        {
          "HGVS": "NM_001126112.3:c.1151A>G",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "G",
            "position": "1151"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "S",
            "position": "384"
          },
          "Description in input context": "p.N551K"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0000621"
  },
  "Experiment Method": [
    {
      "Assay Method": "Kinase activity assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Dopaminergic neuronal line",
        "Description": "Experiments were conducted using dopaminergic neuronal cell lines to assess kinase activity of LRRK2 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.1398C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity",
          "Result Description": "p.R1398H showed significantly lower kinase activity compared to wild-type LRRK2."
        },
        {
          "Variant": "NM_001126112.3:c.2385G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased kinase activity",
          "Result Description": "p.G2385R exhibited higher kinase activity than wild-type LRRK2."
        },
        {
          "Variant": "NM_001126112.3:c.1628C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased kinase activity",
          "Result Description": "p.R1628P demonstrated elevated kinase activity compared to wild-type LRRK2."
        },
        {
          "Variant": "NM_001126112.3:c.1151A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity",
          "Result Description": "p.N551K showed reduced kinase activity relative to wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated across multiple biological replicates to validate results."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Technical duplicates were performed to ensure consistency in kinase activity measurements."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control for kinase activity assays."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control in kinase activity experiments."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Relative risk analysis and odds ratios were used to assess variant associations."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 80% of wild-type baseline.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity < 50% of wild-type baseline or > 150%.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}